Reversal setup: Can Boston Scientific stock extend gains?
Boston Scientific (BSX) stock is trading at $48.15, up 2.81% on the day and near its session high. The stock trades above its short-term averages, reflecting strong intraday momentum although it remains capped below medium- and long-term trend lines.
Highlights
- Shares of BSX closed 2.81% higher, but the trend remains constrained by medium- and long-term selling pressure.
- Momentum indicators are mixed, with some overbought signals and others calling for continued weak or negative trend.
- BSX is expected to trade in a $46.59 to $49.71 range, with 55% probability of a move down and resistance at $48.27.
Mixed technical signals as overbought momentum meets resistance
On the technical front, BSX is positioned above its MA-20 but remains below the MA-50 on the hourly and the MA-200 on the daily chart. The Ichimoku Kijun level at $48.27 marks immediate resistance. RSI is at 53.76 and CCI signals Buy, while MACD shows a strong sell and ADX is also leaning bearish, pointing to notable divergence among momentum indicators. Stochastic RSI and Bull/Bear Power are both overbought, indicating strong recent buyer activity, and the Awesome Oscillator sits neutral.
Downside risk grows as rangebound scenario dominates outlook
Looking ahead, BSX is forecast to trade in a volatility band from $46.59 to $49.71 over the next several sessions. The baseline scenario is for rangebound trade within this channel, with a 55% probability of a downward move versus 45% for an upside breakout. A sustained break above resistance at $48.27 could trigger further gains, while a move below support in the lower $46 area would open the door to additional downside.
Earlier, analysts noted that Boston Scientific faced persistent technical headwinds and ongoing downside risks, despite intermittent bursts of buyer activity. The current setup reinforces a cautious stance, with traders advised to monitor the $48.27 resistance level for a potential breakout or the $46 area for renewed downside momentum in the coming sessions.